Differential Diagnosis of Uveitic Macular Edema

  • Ilaria Testi
  • Andres Rousselot
  • Rupesh Agrawal
  • Carlos Pavesio


Macular edema (ME) commonly occurs in uveitis entities with posterior segment involvement as Birdshot retinochoroiditis, intermediate uveitis, acute retinal necrosis, sarcoidosis and Behçet’s disease. Among isolated anterior uveitis, HLA-B27 uveitis and juvenile idiopathic arthritis can be complicated by ME due to, respectively, acute recurrent inflammatory attacks and long term chronic active inflammation. Identify the underlying cause, distinguishing among infectious and noninfectious uveitis, and recognize the specific clinical entity is mandatory for instituting an appropriate therapy and preventing risk of functional visual loss.


Macular edema Differential diagnosis Anterior uveitis Intermediate uveitis Posterior uveitis Retinal vasculitis Infectious Autoimmune 


  1. 1.
    Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332–6.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Fardeau C, Champion E, Massamba N, LeHoang P. Uveitic macular edema. Eye (Lond). 2016;30(10):1277–92.Google Scholar
  3. 3.
    Lardenoye CW, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113(8):1446–9.PubMedGoogle Scholar
  4. 4.
    Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–16.PubMedGoogle Scholar
  5. 5.
    Wakefield D, Yates W, Amjadi S, McCluskey P. HLA-B27 anterior uveitis: immunology and immunopathology. Ocul Immunol Inflamm. 2016;24(4):450–9.PubMedGoogle Scholar
  6. 6.
    Kopplin LJ, Mount G, Suhler EB. Review for disease of the year: epidemiology of HLA-B27 associated ocular disorders. Ocul Immunol Inflamm. 2016;24(4):470–5.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Khan MA. Update on spondyloarthropathies. Ann Intern Med. 2002;136:896–907.PubMedGoogle Scholar
  8. 8.
    Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology. 1994;101:1267–74.PubMedGoogle Scholar
  9. 9.
    D’Ambrosio EM, La Cava M, Tortorella P, Gharbiya M, Campanella M, Iannetti L. Clinical features and complications of the HLA-B27-associated acute anterior uveitis: a metaanalysis. Semin Ophthalmol. 2017;32(6):689–701.PubMedGoogle Scholar
  10. 10.
    Agarwal A, Pichi F, Invernizzi A, Gupta V. Disease of the year: differential diagnosis of uveitic macular edema. Ocul Immunol Inflamm. 2018;1:1–17.Google Scholar
  11. 11.
    Sungur G, Yakin M, Uzman S, Balta O, Orman G, Ornek F. Clinical features and prognosis of uveitis in a Turkish patient population with ankylosing spondylitis: incidence and management of ocular complications. Ocul Immunol Inflamm. 2018;23:1–9.Google Scholar
  12. 12.
    Majumdar AK, Kumar A, Roy R, Dutta Majumder P. Clinical profile of HLA B-27-associated uveitis patients in a tertiary care eye hospital in Eastern India. Ocul Immunol Inflamm. 2018;16:1–4.Google Scholar
  13. 13.
    Tugal-Tutkun I, Otük-Yasar B, Altinkurt E. Clinical features and prognosis of herpetic anterior uveitis: a retrospective study of 111 cases. Int Ophthalmol. 2010;30(5):559–65.PubMedGoogle Scholar
  14. 14.
    Miserocchi E, Waheed NK, Dios E, et al. Visual outcome in herpes simplex virus and varicella zoster virus uveitis. A clinical evaluation and comparison. Ophthalmology. 2002;109:1532–7.PubMedGoogle Scholar
  15. 15.
    Chee S-P, Bacsal K, Jap A, S-Y S-T, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;145(5):834–40.PubMedGoogle Scholar
  16. 16.
    Bouchenaki N, Herbort CP. Fuchs’ uveitis: failure to associate vitritis and disc hyperfluorescence with the disease is the major factor for misdiagnosis and diagnosis delay. Middle East Afr J Ophthalmol. 2009;16:239–44.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Al-Mansour YS, Al-Rajhi AA, Al-Dhibi H, Abu El-Asrar AM. Clinical features and prognostic factors in Fuchs’ uveitis. Int Ophthalmol. 2010;30(5):501–9.PubMedGoogle Scholar
  18. 18.
    De Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87:879–84.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Abu Samra K, Maghsoudlou A, Roohipoor R, Valdes-Navarro M, Lee S, Foster CS. Current treatment modalities of JIA-associated uveitis and its complications: literature review. Ocul Immunol Inflamm. 2016;24(4):431–9.PubMedGoogle Scholar
  20. 20.
    Vitale AT, Graham E, de Boer JH. Juvenile idiopathic arthritis associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome. Ocul Immunol Inflamm. 2013;21(6):478–85.PubMedGoogle Scholar
  21. 21.
    Ducos de Lahitte G, Terrada C, Tran TH, et al. Maculopathy in uveitis of juvenile idiopathic arthritis: an optical coherence tomography study. Br J Ophthalmol. 2008;92(1):64–9.PubMedGoogle Scholar
  22. 22.
    Kalinina Ayuso V, Ten Cate HA, van der Does P, Rothova A, de Boer JH. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149(6):994–999.e5.PubMedGoogle Scholar
  23. 23.
    Babu BM, Rathinam SR. Intermediate uveitis. Indian J Ophthalmol. 2010;58:21–7.PubMedGoogle Scholar
  24. 24.
    Niederer RL, Sharief L, Bar A, Lightman SL, Tomkins-Netzer O. Predictors of long-term visual outcome in intermediate uveitis. Ophthalmology. 2017;124(3):393–8.PubMedGoogle Scholar
  25. 25.
    Sharief L, Lightman S, Blum-Hareuveni T, Bar A, Tomkins-Netzer O. Clinical outcome of retinal Vasculitis and predictors for prognosis of ischemic retinal Vasculitis. Am J Ophthalmol. 2017;177:206–12.PubMedGoogle Scholar
  26. 26.
    Abu El-Asrar AM, Herbort CP, Tabbara KF. Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol. 2009;16(4):202–18.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Herbort CP, Rao NA, Mochizuki M, members of Scientific Committee of First International Workshop on Ocular Sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–9.PubMedGoogle Scholar
  28. 28.
    Agrawal R, Kee AR, Ang L, et al. Tuberculosis or sarcoidosis: opposite ends of the same disease spectrum? Tuberculosis (Edinb). 2016;98:21–6.Google Scholar
  29. 29.
    Gass JD, Olson CL. Sarcoidosis with optic nerve and retinal involvement. Arch Ophthalmol. 1976;94(6):945–50.PubMedGoogle Scholar
  30. 30.
    Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol. 2000;84:110–6.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular edema in multiple sclerosis is associated with disease severity. Brain. 2012;135(Pt 6):1786–93.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Saidha S, Sotirchos ES, Oh J, Syc SB, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol. 2013;70(1):34–43.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Brar M, Yuson R, Kozak I, et al. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema. Retina. 2010;30:383–9.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Zierhut M, Abu El-Asrar AM, Bodaghi B, Tugal-Tutkun I. Therapy of ocular Behçet disease. Ocul Immunol Inflamm. 2014;22(1):64–76.PubMedGoogle Scholar
  36. 36.
    Herbort CP, Pavésio C, LeHoang P, et al. Why birdshot retinochoroiditis should rather be called ‘HLA-A29 uveitis’? Br J Ophthalmol. 2017;101(7):851–5.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Carreras E, Salomão DR, Nadal J, et al. Macular edema is a rare finding in untreated vitreoretinal lymphoma: small case series and review of the literature. Int J Retina Vitreous. 2017;3:15.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Ouyang Y, Li F, Shao Q, et al. Subretinal fluid in eyes with active ocular toxoplasmosis observed using spectral domain optical coherence tomography. PLoS One. 2015;10(5):e0127683.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Ouyang Y, Pleyer U, Shao Q, et al. Evaluation of cystoid change phenotypes in ocular toxoplasmosis using optical coherence tomography. PLoS One. 2014;9(2):e86626.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Davis JL. Ocular syphilis. Curr Opin Ophthalmol. 2014;25(6):513–8.PubMedGoogle Scholar
  41. 41.
    Gunasekeran DV, Gupta B, Cardoso J, Pavesio CE, Agrawal R. Visual morbidity and ocular complications in presumed intraocular tuberculosis: an analysis of 354 cases from a non-endemic population. Ocul Immunol Inflamm. 2018;26(6):865–9.PubMedGoogle Scholar
  42. 42.
    Torres RM, Calonge M. Macular edema as the only ocular finding of tuberculosis. Am J Ophthalmol. 2004;138(6):1048–9.PubMedGoogle Scholar
  43. 43.
    Martin NF, Fitzgerald CR. Cystoid macular edema as the primary sign of neurosyphilis. Am J Ophthalmol. 1979;88(1):28–31.PubMedGoogle Scholar
  44. 44.
    Ortega-Evangelio L, Navarrete-Sanchis J, Williams BK, Tomás-Torrent JM. Aflibercept in the management of acute retinal necrosis syndrome-related macular edema. Eur J Ophthalmol. 2018;28(2):259–61.PubMedGoogle Scholar
  45. 45.
    Urban B, Bakunowicz-Łazarczyk A, Michalczuk M. Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment. Mediat Inflamm. 2014;2014:971417.Google Scholar
  46. 46.
    Aggarwal K, Agarwal A, Katoch D, Sharma M, Gupta V. Optical coherence tomography angiography features of acute macular neuroretinopathy in dengue fever. Indian J Ophthalmol. 2017;65(11):1235–8.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Afshar AR, Hariprasad SM, Jampol LM, Sheth VS. Use of intravitreous bevacizumab to treat macular edema in West Nile virus chorioretinitis. Arch Ophthalmol. 2012;130(3):396–8.PubMedGoogle Scholar
  48. 48.
    Minos E, Barry RJ, Southworth S, et al. Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment. Orphanet J Rare Dis. 2016;11(1):61.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Rothova A, Berendschot TT, Probst K, van Kooij B, Baarsma GS. Birdshot chorioretinopathy: long term manifestations and visual prognosis. Ophthalmology. 2004;111(5):954–9.PubMedGoogle Scholar
  50. 50.
    Levinson RD, Brezin A, Rothova A, Accorinti M, Holland GN. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am J Ophthalmol. 2006;141(1):185–7.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Ilaria Testi
    • 1
  • Andres Rousselot
    • 2
  • Rupesh Agrawal
    • 1
    • 3
    • 4
  • Carlos Pavesio
    • 1
  1. 1.Moorfields Eye HospitalNHS Foundation TrustLondonUK
  2. 2.Department of OphthalmologyUniversidad del Salvador of Buenos AiresBuenos AiresArgentina
  3. 3.National Healthcare Group Eye InstituteTan Tock Seng HospitalSingaporeSingapore
  4. 4.Singapore Eye Research InstituteSingaporeSingapore

Personalised recommendations